At the time of writing, Cumberland Pharmaceuticals Inc [CPIX] stock is trading at $1.37, up 23.42%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CPIX shares have gain 25.69% over the last week, with a monthly amount glided 10.48%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cumberland Pharmaceuticals Inc [NASDAQ: CPIX] stock has seen the most recent analyst activity on November 12, 2012, when UBS reiterated its Neutral rating and also revised its price target to $5 from $6.50. Previously, UBS reaffirmed its Neutral rating on February 01, 2011, and dropped its price target to $6.50. On December 16, 2010, downgrade downgraded it’s rating to Neutral and revised its price target to $8 on the stock. UBS reiterated its Buy rating and decreased its price target to $10 on August 17, 2010. Morgan Joseph reiterated its recommendation of a Buy and reduced its price target to $10 on August 17, 2010. Jefferies downgraded its rating to Hold for this stock on August 17, 2010, and downed its price target to $5.50. In a note dated May 14, 2010, Morgan Joseph reiterated an Buy rating on this stock and revised its target price from $21 to $15.
For the past year, the stock price of Cumberland Pharmaceuticals Inc fluctuated between $1.04 and $2.36. Cumberland Pharmaceuticals Inc [NASDAQ: CPIX] shares were valued at $1.37 at the most recent close of the market.
Analyzing the CPIX fundamentals
According to Cumberland Pharmaceuticals Inc [NASDAQ:CPIX], the company’s sales were 36.79M for trailing twelve months, which represents an -9.92% plunge. Gross Profit Margin for this corporation currently stands at 0.74% with Operating Profit Margin at -0.19%, Pretax Profit Margin comes in at -0.29%, and Net Profit Margin reading is -0.3%. To continue investigating profitability, this company’s Return on Assets is posted at -0.14, Equity is -0.4 and Total Capital is -0.16. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.65.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.0967 points at the first support level, and at 0.8233 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.6167, and for the 2nd resistance point, it is at 1.8633.
Ratios To Look Out For
It is important to note that Cumberland Pharmaceuticals Inc [NASDAQ:CPIX] has a current ratio of 1.13. Further, the Quick Ratio stands at 0.99, while the Cash Ratio is 0.56. Considering the valuation of this stock, the price to sales ratio is 0.65, the price to book ratio is 0.77.
